Boehringer Ingelheim, Investment Arm

Boehringer Ingelheim, Investment Arm is a venture capital firm specializing in start up and early stage investments. The firm seeks to invest in life sciences, digital health, biotechnology and medical science with a focus on novel technologies, next generation vaccines, new biological entities, novel therapeutic targets, disease-related biomarkers, personalized medicine, and new approaches in regenerative medicine. The firm prefers to invest in companies based in North America and Europe/Israel. It typically invests up to €15 million ($17.84 million) over company's lifetime (up to €7.5 million ($8.92 million) for Digital Health companies). Boehringer Ingelheim, Investment Arm was founded in 2010 and is based in Ingelheim am Rhein, Germany with an additional office in Cambridge, Massachusetts and Beijing, China.